Curocell Inc

372320

Company Profile

  • Business description

    Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

  • Contact

    11, Gukjegwahak 16-ro
    Yuseong-gu
    Daejeon34002
    KOR

    T: +82 428633698

    https://www.curocellbtx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    140

Stocks News & Analysis

stocks

Are small caps finally back?

Does renewed investor interest point to a structural shift in the underperforming factor?
stocks

Chart of the Week: Modest earnings growth at odds with overvalued bank shares

The latest update from our Industry Pulse report.
stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,295.8017.600.19%
CAC 408,206.8751.99-0.63%
DAX 4024,151.13178.90-0.74%
Dow JONES (US)46,590.41334.33-0.71%
FTSE 1009,515.0088.010.93%
HKSE25,781.77245.78-0.94%
NASDAQ22,740.40213.27-0.93%
Nikkei 22549,307.798.27-0.02%
NZX 50 Index13,316.269.820.07%
S&P 5006,699.4035.95-0.53%
S&P/ASX 2009,004.5018.300.20%
SSE Composite Index3,913.762.57-0.07%

Market Movers